versión imprimible
 
 

Cytokine-Based Cancer Immunotherapies Summit

Evvnt Promotion / evvnt
-
24.03.2021 - 25.03.2021  Virtual
Time: 08:00 to 17:00
 
Temas de la conferencia
This is the primary industry platform dedicated to providing you insight into the latest clinical results and stimulating discussions around
how to take cytokine-based immunotherapy combinations forward.

The renewed interest in the anti-tumor properties of cytokines has led to an increase in the number of clinical trials that explore the safety and efficacy of cytokine-based drugs, not only as single agents, but also in combination with other immunomodulatory drugs.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/708655-2?pid=4832

Speakers: Ruth Ganss, Professor in Translational Cancer Research, Harry Perkins Institute of Medical Research, University of Western Australia, and more.
 

Información e inscripción:

https://go.evvnt.com/708655-1?pid=4832
Mr. Customer Services
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Digital Conference Only - Drug Developer Pricing: USD 1999.00, Digital Conference Only - Service Provider Pricing: USD 2499.00, Digital Conference Only - Academic Pricing: USD 1799.00
Los participantes esperaban
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Helix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)newTreeÖsterreichische Akademie der ÄrzteÄrzte der Welt